MOTS-c

Overview

MOTS-c is distinct among research peptides in that it is encoded not in the nuclear genome but within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. Preclinical research has examined its effects on AMP-activated protein kinase (AMPK) activation, a central regulator of cellular energy sensing, and on glucose uptake dynamics in skeletal muscle tissue. A notable area of investigation concerns its observed translocation from the mitochondria to the nucleus in response to metabolic stress, where it has been observed to interact with nuclear gene networks involved in metabolic regulation.

Preclinical models have investigated MOTS-c across metabolic, musculoskeletal, and cardiovascular research contexts. Studies have examined its effects on glucose uptake, insulin sensitivity markers, lipid oxidation, and skeletal muscle metabolism in the context of mitochondrial biology and metabolic research.

Chemical Profile

Preclinical Research Findings

Glucose Metabolism and AMPK Signaling Research

MOTS-c has been examined in preclinical models for its effects on glucose uptake in skeletal muscle tissue through AMPK activation. Studies using in vitro cell models and rodent models have investigated changes in glucose transporter activity, insulin signaling pathways, and metabolic flux following MOTS-c administration. Research has also examined its role in the FOXO1-AMPK axis and metabolic gene expression in muscle and adipose tissue contexts. A distinct area of research concerns MOTS-c’s observed translocation to the nucleus under metabolic stress conditions, where it has been reported to interact with the antioxidant response element (ARE) and modulate nuclear gene expression involved in cellular energy adaptation.

Bone Biology and Collagen Research

Preclinical investigations have examined MOTS-c for its effects on osteoblast differentiation and type I collagen synthesis in bone tissue models. Studies have explored its activity through the TGF-β/SMAD signaling pathway, which is involved in osteoblast regulation. Research in ovariectomized rodent models — commonly used as a preclinical model for estrogen-deficient bone loss — has examined changes in bone tissue markers and collagen-related gene expression following MOTS-c administration.

Areas of Preclinical Research

• AMPK pathway activation and glucose metabolism studies
• Skeletal muscle energy regulation and insulin signaling research
• Mitochondrial-nuclear signaling and metabolic stress response studies
• Osteoblast biology and TGF-β/SMAD pathway research
• Adipose tissue metabolism and lipid oxidation studies

Research Use Only: This product is sold exclusively for laboratory and scientific research. It is not approved for human or veterinary use or consumption.

Disclaimer: All products distributed by Resolve Peptides are supplied exclusively for controlled laboratory and scientific research. They are not drugs, supplements, or therapies, and have not been approved by the FDA or any regulatory authority for human or veterinary use. These products are not intended for human or veterinary administration. Regulatory status of research peptides is subject to change; it is the responsibility of the researcher to verify current applicable regulations in their jurisdiction prior to purchase. Any references to biological effects are based solely on experimental and preclinical data.